NO20001608D0 - Et multicellulært in vitro angiogeneseassay - Google Patents

Et multicellulært in vitro angiogeneseassay

Info

Publication number
NO20001608D0
NO20001608D0 NO20001608A NO20001608A NO20001608D0 NO 20001608 D0 NO20001608 D0 NO 20001608D0 NO 20001608 A NO20001608 A NO 20001608A NO 20001608 A NO20001608 A NO 20001608A NO 20001608 D0 NO20001608 D0 NO 20001608D0
Authority
NO
Norway
Prior art keywords
multicellular
vitro
angiogenesis assay
vitro angiogenesis
angiogenesis
Prior art date
Application number
NO20001608A
Other languages
English (en)
Other versions
NO20001608L (no
Inventor
Ellen Tennant Grand
Graham Thomas Bell
Stephen Bloor
Original Assignee
Biocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocure Ltd filed Critical Biocure Ltd
Publication of NO20001608L publication Critical patent/NO20001608L/no
Publication of NO20001608D0 publication Critical patent/NO20001608D0/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20001608A 1997-10-01 2000-03-28 Et multicellulært in vitro angiogeneseassay NO20001608D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720987.8A GB9720987D0 (en) 1997-10-01 1997-10-01 A multicellular in vitro assay of angiogenesis
PCT/GB1998/002908 WO1999017116A1 (en) 1997-10-01 1998-09-25 A multicellular in vitro assay of angiogenesis

Publications (2)

Publication Number Publication Date
NO20001608L NO20001608L (no) 2000-03-28
NO20001608D0 true NO20001608D0 (no) 2000-03-28

Family

ID=10819980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001608A NO20001608D0 (no) 1997-10-01 2000-03-28 Et multicellulært in vitro angiogeneseassay

Country Status (15)

Country Link
EP (1) EP1023599B1 (no)
JP (1) JP3404572B2 (no)
AT (1) ATE218209T1 (no)
AU (1) AU732538B2 (no)
CA (1) CA2301171C (no)
DE (1) DE69805644T2 (no)
DK (1) DK1023599T3 (no)
ES (1) ES2174486T3 (no)
GB (1) GB9720987D0 (no)
IL (1) IL135386A0 (no)
MY (1) MY119061A (no)
NO (1) NO20001608D0 (no)
NZ (1) NZ502962A (no)
WO (1) WO1999017116A1 (no)
ZA (1) ZA988936B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US6599694B2 (en) 2000-12-18 2003-07-29 Cytokinetics, Inc. Method of characterizing potential therapeutics by determining cell-cell interactions
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
ES2185493B1 (es) * 2001-07-03 2004-06-16 Madrid Genetics, S.L. Metodo para evaluar in vitro en condiciones fisiologicas o patologicas relevantes la actividad biologica de compuestos a gran escala.
WO2005010677A2 (en) 2003-07-18 2005-02-03 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
US8679836B2 (en) 2007-10-01 2014-03-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539716A (en) * 1981-03-19 1985-09-10 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
US4546500A (en) * 1981-05-08 1985-10-15 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5759830A (en) * 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix

Also Published As

Publication number Publication date
JP2001518621A (ja) 2001-10-16
CA2301171A1 (en) 1999-04-08
EP1023599B1 (en) 2002-05-29
AU9178598A (en) 1999-04-23
IL135386A0 (en) 2001-05-20
DK1023599T3 (da) 2002-07-08
AU732538B2 (en) 2001-04-26
DE69805644D1 (de) 2002-07-04
WO1999017116A1 (en) 1999-04-08
JP3404572B2 (ja) 2003-05-12
CA2301171C (en) 2002-11-12
NO20001608L (no) 2000-03-28
ES2174486T3 (es) 2002-11-01
DE69805644T2 (de) 2002-09-12
GB9720987D0 (en) 1997-12-03
NZ502962A (en) 2001-01-26
MY119061A (en) 2005-03-31
ZA988936B (en) 1999-03-31
EP1023599A1 (en) 2000-08-02
ATE218209T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
NO20001608D0 (no) Et multicellulært in vitro angiogeneseassay
ATE331025T2 (de) Medium für die protein- und serumfreie zellkultur
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
DE69617583T2 (de) In vitrozellkultur-System
HK1091228A1 (en) Methods for making recombinant proteins using apoptosis inhibitors
DE69725587D1 (de) Verwendung von wnt polypeptiden
DE60020855D1 (de) Bedingte immortalisierung von zellen
ATE226632T1 (de) Serumfreies medium für säugetierzellen
DE3875396D1 (de) Mikrotraegermaterial fuer die zellkultur.
DE59804256D1 (de) Kleinsteuerung
ES2175680T3 (es) Soporte.
SE8501534L (sv) Interferon epsilon
FR2716205B1 (fr) Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
TR200000140T2 (tr) Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi
PT880594E (pt) Vector retroviral e sua utilizacao em terapia genica
DK0851028T3 (da) Immortaliseret human hornhindeepitalcellelinje
IL97048A0 (en) Bioluminescence assay for gene expression in growing mammalian cells
DE69836336D1 (de) Regulation der ausschleusung von proteinen
DE69634363D1 (de) Vorläufer von normalen neuralen epithelzellen
DK0994955T3 (da) Öget produktion af secernerede proteiner med rekombinante gærceller
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
EA200701000A1 (ru) Культуральная среда для клеток млекопитающих, не содержащая сыворотки
DE3675631D1 (de) In-vitro-kulturverfahren.
ES1038242U (es) Maqueta con base segmentada perfeccionada.
IT1148163B (it) Diagnostica con immonoflurescenza od immunoperossidasi su cellule di coltura infettate in vitro

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application